73 related articles for article (PubMed ID: 27193704)
41. Assessment of clonal stability of minimal residual disease targets between 1st and 2nd relapse of childhood precursor B-cell acute lymphoblastic leukemia.
Guggemos A; Eckert C; Szczepanski T; Hanel C; Taube T; van der Velden VH; Graf-Einsiedel H; Henze G; Seeger K
Haematologica; 2003 Jul; 88(7):737-46. PubMed ID: 12857551
[TBL] [Abstract][Full Text] [Related]
42. Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma.
Hosler GA; Bash RO; Bai X; Jain V; Scheuermann RH
Am J Pathol; 1999 Apr; 154(4):1023-35. PubMed ID: 10233841
[TBL] [Abstract][Full Text] [Related]
43. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
44. Predicting outcome in childhood acute lymphoblastic leukemia using gene expression profiling: prognostication or protocol selection?
Catchpoole D; Guo D; Jiang H; Biesheuvel C
Blood; 2008 Feb; 111(4):2486-7; author reply 2487-8. PubMed ID: 18263786
[No Abstract] [Full Text] [Related]
45. Management of adults with T-cell lymphoblastic leukemia.
Marks DI; Rowntree C
Blood; 2017 Mar; 129(9):1134-1142. PubMed ID: 28115371
[TBL] [Abstract][Full Text] [Related]
46. Advanced lymphoblastic clones detection in T-cell leukemia.
Minervina AA; Komkov AY; Mamedov IZ; Lebedev YB
Dokl Biochem Biophys; 2016 Mar; 467(1):85-8. PubMed ID: 27193704
[TBL] [Abstract][Full Text] [Related]
47. [Characteristics of T cell receptor beta gene rearrangements and its role in minimal residual disease detection in childhood T-cell acute lymphoblastic leukemia].
Liu JY; Li ZG; Gao C; Cui L; Wu MY
Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):487-92. PubMed ID: 19099802
[TBL] [Abstract][Full Text] [Related]
48. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
Chan DW; Liang R; Kwong YL; Chan V
Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
[TBL] [Abstract][Full Text] [Related]
49. T cell receptor gamma (TCRG) gene rearrangements in Brazilian children with acute lymphoblastic leukemia: analysis and implications for the study of minimal residual disease.
Scrideli CA; Queiróz RG; Kashima S; Sankarankutty BO; Tone LG
Leuk Res; 2004 Mar; 28(3):267-73. PubMed ID: 14687622
[TBL] [Abstract][Full Text] [Related]
50. Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia.
Brüggemann M; van der Velden VH; Raff T; Droese J; Ritgen M; Pott C; Wijkhuijs AJ; Gökbuget N; Hoelzer D; van Wering ER; van Dongen JJ; Kneba M
Leukemia; 2004 Apr; 18(4):709-19. PubMed ID: 14961040
[TBL] [Abstract][Full Text] [Related]
51. Detection of T-cell receptor delta gene rearrangement by clonal specific polymerase chain reaction.
Chan DW; Liang R; Chan V; Kwong YL; Chan TK
Leukemia; 1997 Apr; 11 Suppl 3():281-4. PubMed ID: 9209365
[TBL] [Abstract][Full Text] [Related]
52. The clinical path to integrated genomics in ALL.
Bourquin JP
Blood; 2014 Aug; 124(9):1380-1. PubMed ID: 25170109
[TBL] [Abstract][Full Text] [Related]
53. Biological markers in haematological malignancies.
Lemal R; Tournilhac O; Bay JO
Bull Cancer; 2014 Jun; 101 Suppl 1():S7-11. PubMed ID: 24966076
[TBL] [Abstract][Full Text] [Related]
54. Preparing unbiased T-cell receptor and antibody cDNA libraries for the deep next generation sequencing profiling.
Mamedov IZ; Britanova OV; Zvyagin IV; Turchaninova MA; Bolotin DA; Putintseva EV; Lebedev YB; Chudakov DM
Front Immunol; 2013; 4():456. PubMed ID: 24391640
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
